NEW YORK (GenomeWeb News) – Data-mining software firm Compumine said last week that it has licensed its Rule Discovery System product to AstraZeneca in Sweden.
 
AstraZeneca will use the technology “to improve compound selection throughout its chemistry domains,” the company said in a statement.
 
Niklas Blomberg, associate director of computational chemistry at AstraZeneca, said in a statement that the software enables his team to predict “important safety and physical-chemical properties of our compounds.”

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.

Mar
13
Sponsored by
Agilent

This webinar will share how clinical genetics labs can integrate cytogenetics and molecular data to assess abnormalities using a single sample on a single workflow platform.